Literature DB >> 3090134

Clinical relevance of gastroduodenal dysfunction in reflux esophagitis.

A Dubois.   

Abstract

This review critically evaluates the gastroduodenal factors that may play a clinically relevant role in the pathogenesis of reflux esophagitis. The gastroesophageal pressure gradient is of obvious importance, but the role of gastric contraction/relaxation is poorly understood. The intragastric volume, as well as the factors that influence it, could theoretically play a role in gastroesophageal reflux (GER). For example, suppression of gastric emptying and gastric motility would be expected to increase GER, and treatment with gastrokinetic agents appears to provide symptomatic improvement. However, only a fraction of patients with GER have delayed gastric emptying, and there is no correlation between either subjective epigastric fullness or esophagitis on one hand and gastric emptying on the other hand. Gastric acid and pepsin, and possibly the hypersecretion of acid, play a pivotal role in reflux esophagitis, as demonstrated by the efficacy of the treatment with histamine H2 antagonists and antacids. Other important factors in experimental esophagitis are duodenogastric reflux, the presence of bile acids in the gastric contents, as well as trypsin if the pH is alkaline. It is suggested that these important findings may lead to novel therapeutic approaches of reflux esophagitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090134     DOI: 10.1097/00004836-198606001-00005

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  Esophagitis impairs esophageal smooth muscle reactivity in the rat model: an in vitro study.

Authors:  Melih Tugay; Firuzan Yildiz; Tijen Utkan; Bahar Müezzinoğlu; Faruk Erden; Nejat Gacar; Güner Ulak
Journal:  Dig Dis Sci       Date:  2003-11       Impact factor: 3.199

2.  Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease.

Authors:  G J Maddern; G G Jamieson; J C Myers; P J Collins
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

3.  Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.

Authors:  M L Cloud; W W Offen
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

4.  Solid-phase gastric emptying in patients with Barrett's esophagus.

Authors:  D A Johnson; C Winters; W E Drane; E L Cattau; K C Karvelis; E D Silverman; T J Spurling; S J Chobanian; A Dubois
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

5.  The role of esophageal motility and hiatal hernia in esophageal exposure to acid.

Authors:  E S Xenos
Journal:  Surg Endosc       Date:  2002-02-27       Impact factor: 4.584

6.  Duodenogastric reflux in patients with Barrett's esophagus.

Authors:  J P Waring; J Legrand; A Chinichian; R A Sanowski
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

7.  Healing and prevention of relapse of reflux oesophagitis by cisapride.

Authors:  J Toussaint; A Gossuin; M Deruyttere; F Hublé; G Devis
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Relations among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease.

Authors:  K M Cunningham; M Horowitz; P S Riddell; G J Maddern; J C Myers; R H Holloway; J M Wishart; G G Jamieson
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.